Wu-Ching Uen
Overview
Explore the profile of Wu-Ching Uen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
167
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lin L, Uen W, Choong C, Shi Y, Lee B, Tai C, et al.
Molecules
. 2019 Jun;
24(11).
PMID: 31163662
Colorectal cancer is one of the most common cancers worldwide and chemotherapy is the main approach for the treatment of advanced and recurrent cases. Developing an effective complementary therapy could...
2.
Uen W, Choong C, Tai C, Tai C
Evid Based Complement Alternat Med
. 2019 Mar;
2019:7035087.
PMID: 30915150
Objective: Leukemia is a cancer of the blood cells. Leukemic THP-1 and U937 cells were used in this study as monocytic effectors cells for proliferation responses and macrophage-like cells induction...
3.
Uen W, Lee B, Shi Y, Wu S, Tai C, Tai C
J Tradit Complement Med
. 2018 Jan;
8(1):220-225.
PMID: 29322012
The present study is designed to investigate the anti-oral cancer properties of on oral squamous cell carcinoma. is a Chinese herb used for suppression of various cancers. However, the inhibition...
4.
Uen W, Hsieh C, Tseng T, Jiang S, Tseng J, Lee S
Melanoma Res
. 2014 Nov;
25(1):35-46.
PMID: 25426644
Metastasis of melanoma cells during the recurrence or the late stage of melanoma has been characterized as the dissemination of tumor cells under anchorage independency. The secreted interleukin-8 (IL-8) and...
5.
Huang W, Chen H, Yeh C, Lu Y, Hwang W, Huang J, et al.
J Investig Med
. 2013 Sep;
61(7):1108-14.
PMID: 24013526
Objective: This postmarketing surveillance study evaluated the safety and efficacy of cetuximab therapy in patients with epidermal growth factor receptor (EGFR)-expressing metastatic colorectal cancer (mCRC) in Taiwan. Methods: Patients with...
6.
Hsieh R, Huang C, Uen W
J Altern Complement Med
. 2011 Aug;
17(9):871-4.
PMID: 21875353
Objectives: The objective of this study was to describe a serious complication of acupuncture treatment in a high-risk patient with aplastic anemia. Design: A 44-year-old woman with aplastic anemia experienced...
7.
Improving Detection Accuracy of Lung Cancer Serum Proteomic Profiling via Two-Stage Training Process
Hsu P, Wang Y, Huang S, Lin Y, Chang C, Tsang Y, et al.
Proteome Sci
. 2011 Apr;
9(1):20.
PMID: 21496334
Background: Surface-Enhanced Laser Desorption/Ionization Time-of-Flight Mass Spectrometry (SELDI-TOF-MS) is a frequently used technique for cancer biomarker research. The specificity of biomarkers detected by SELDI can be influenced by concomitant inflammation....
8.
Uen W, Tai C, Shen S, Lee W, Tsao T, Deng W, et al.
J Mol Histol
. 2010 Aug;
41(4-5):259-66.
PMID: 20734115
Colorectal glands are important functional organs in colorectal tissue and are also the origin of colorectal carcinomas. Epithelial cell polarization of colorectal glands is related to structural integrity and physiological...
9.
Su W, Wen C, Hsiung C, Su I, Cheng A, Chang M, et al.
World J Gastroenterol
. 2005 Sep;
11(34):5283-8.
PMID: 16149133
Aim: To investigate the long-term consequences of chemotherapy-related HBV reactivation in patients with lymphoma. Methods: This study was based on the database of published prospective study evaluating HBV reactivation in...
10.
Cheng A, Hsiung C, Su I, Chen P, Chang M, Tsao C, et al.
Hepatology
. 2003 May;
37(6):1320-8.
PMID: 12774010
Reactivation of hepatitis is one of the most serious complications of chemotherapy in lymphoma patients who are carriers of the hepatitis B virus (HBV). Glucocorticoids are linked to increased risk...